Free Newsletter
Hospira finishes for Genzyme
Genzyme has tapped Hospira for fill and finish of Cerezyme and Fabrazyme, helping to alleviate shortages of two key drugs. The Boston-based big biotech is still struggling to get its Allston Landing plant up to full compliance following last summer's shutdown. Report
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
SHARE
WITH: